ORTHOFIX® 1 Improving patient mobility through innovation Forward-Looking Statements and Non-GAAP Financial Measures 2 2 Except for historical information contained herein, the statements made in this presentation constitute forward-looking statements that involve certain risks and uncertainties. These forward-looking statements are based on our beliefs and expectations as of August 5, 2022, and we do not undertake any obligation to revise or update such forward looking statements, which speak only as of su ...

Orthofix Medical Inc. (NASDAQ:OFIX) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Alexa Huerta – Senior Director-Investor Relations Jon Serbousek – President and Chief Executive Officer Doug Rice – Chief Financial Officer Conference Call Participants Mathew Blackman – Stifel Jeffrey Cohen – Ladenburg Jim Sidoti – Sidoti and Company Operator Hello, and a warm welcome to Orthofix Medical’s Q2 2022 Earnings Call. My name is Melissa, and I’ll be your operator today. [Operator I ...

FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisdictio ...

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Jon Serbousek – Director, President and Chief Executive Officer Doug Rice – Chief Financial Officer Alexa Huerta – Senior Director of Investor Relations and Finance Conference Call Participants Mathew Blackman – Stifel Financial Corp. Jeffrey Cohen – Ladenburg Thalmann & Co. Inc. Jim Sidoti – Sidoti & Company, LLC Operator Good morning, everyone and welcome to today's Orthofix Medical First Quart ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 98-1340767 (State or other jurisdiction of incorporation or organization) 3451 Plano Parkway, Lewisville, Texas 75056 (Address of principal executive offices) (Zip Code) (214) 937-2000 (Registrant's telephone number, including area code) For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SEC ...

©2022 SeaSpine Orthopedics Corporation. All rights reserved | 1 Operate in the Now Keith C. Valentine President & Chief Executive Officer March 11, 2022  SeaSpine. Forward-looking Statements & Disclaimer This presentation is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any securities of SeaSpine Holdings Corp. ("SeaSpine" or the "Company"). This presentation includes certain information obtained from trade and statistical services, third-party publication ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) ...

FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisd ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Not applicable (Former name, former address and former fiscal year, if changed since last report) Indicate by check mark whether the registrant: (1) has fil ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisdiction of incorporation or organization) 3451 Plano Parkway, Lewisville, Texas 75056 (Address of principal executive offices) (Zip Code) (214) 937-2000 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period end ...